Rivaroxaban Clinical Trials

20 recruitingDrug
Phase 47Phase 34Not Applicable3Early Phase 11Phase 11

Showing 120 of 20 trials

Recruiting
Phase 4

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Staphylococcus Aureus BacteremiaStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia+3 more
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06650501
Recruiting
Phase 1

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Healthy Participants
AstraZeneca186 enrolled2 locationsNCT07312851
Recruiting
Phase 3

Thromboprophylaxis in Lower Limb Immobilisation

ThrombosisInjury Leg
Queen Mary University of London10,044 enrolled3 locationsNCT06370273
Recruiting
Not Applicable

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk100 enrolled1 locationNCT07270263
Recruiting
Phase 4

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Atrial Fibrillation
Ottawa Hospital Research Institute3,018 enrolled8 locationsNCT04642430
Recruiting
Early Phase 1

Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

NYU Langone Health50 enrolled1 locationNCT06961630
Recruiting
Not Applicable

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Deep Vein ThrombosisIliac Vein ThrombosisIliac Vein Obstruction+2 more
First Affiliated Hospital of Zhejiang University172 enrolled1 locationNCT04694248
Recruiting
Phase 4

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

Peripartum Cardiomyopathy, Postpartum
Dennis M. McNamara, MD, MS250 enrolled64 locationsNCT05180773
Recruiting

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Cerebral Venous Thrombosis
Hieu Trung Dinh69 enrolled1 locationNCT07083609
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled39 locationsNCT04263038
Recruiting
Phase 4

Anticoagulation in Post MI LV Thrombus Trial in Nepal

Shahid Gangalal National Heart Centre196 enrolled1 locationNCT05794399
Recruiting
Phase 4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Venous ThromboembolismVaricose Veins
Imperial College London6,660 enrolled1 locationNCT05735639
Recruiting
Phase 4

Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization

Radial Artery Occlusion
AHEPA University Hospital80 enrolled1 locationNCT06812455
Recruiting
Not Applicable

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

Atrial Fibrillation
Seoul National University Hospital400 enrolled1 locationNCT06216769
Recruiting

Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

Intracardiac Thrombus
Azienda Ospedaliero, Universitaria Ospedali Riuniti20 enrolled1 locationNCT06371170
Recruiting
Phase 3

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University200 enrolled7 locationsNCT04066764
Recruiting
Phase 3

Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

May-Thurner Syndrome
Second Affiliated Hospital, School of Medicine, Zhejiang University224 enrolled9 locationsNCT04067505
Recruiting

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Pulmonary Embolism
Peking Union Medical College Hospital300 enrolled1 locationNCT06362343
Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

ThrombosisAntiphospholipid SyndromeAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily500 enrolled1 locationNCT04262492
Recruiting
Phase 3

AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation

Aortic Stenosis
Oslo University Hospital360 enrolled3 locationsNCT05035277